Adeline Gallini

Summary

Publications

  1. doi request reprint Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings
    Adeline Gallini
    Universite Paul Sabatier, Toulouse III, Faculte de Medecine, Département d Epidémiologie, économie de la santé et santé publique, F 31073, Toulouse, France INSERM, UMR 1027 Epidémiologie et analyses en santé publique, F 31073, Toulouse, France CHU de Toulouse, Service d épidémiologie, F 31073, Toulouse, France Electronic address
    Eur Neuropsychopharmacol 24:95-104. 2014
  2. doi request reprint Diffusion of antipsychotics in the US And French markets, 1998-2008
    Adeline Gallini
    Department of Epidemiology, University of Toulouse, 37 Allees Jules Guesde, Toulouse 31000, France
    Psychiatr Serv 64:680-7. 2013
  3. doi request reprint Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease
    Adeline Gallini
    INSERM, UMR1027, 31062, Toulouse, France
    Drugs Aging 30:439-45. 2013
  4. doi request reprint A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe : Predictors of Discontinuation and Switch in the ICTUS Study
    Virginie Gardette
    Inserm UMR1027, 31073, Toulouse, France
    CNS Drugs 28:157-70. 2014
  5. pmc The influence of drug use in university hospitals on the pharmaceutical consumption in their surrounding communities
    Adeline Gallini
    Épidémiologie et Analyses en Santé Publique, INSERM, UMR 1027, Toulouse, France
    Br J Clin Pharmacol 75:1142-8. 2013
  6. pmc Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes
    Adeline Gallini
    INSERM, UMR 1027 Epidémiologie et analyses en santé publique risques, maladies chroniques et handicaps Université de Toulouse, UPS Toulouse 3, France
    Br J Clin Pharmacol 72:823-31. 2011

Collaborators

Detail Information

Publications6

  1. doi request reprint Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings
    Adeline Gallini
    Universite Paul Sabatier, Toulouse III, Faculte de Medecine, Département d Epidémiologie, économie de la santé et santé publique, F 31073, Toulouse, France INSERM, UMR 1027 Epidémiologie et analyses en santé publique, F 31073, Toulouse, France CHU de Toulouse, Service d épidémiologie, F 31073, Toulouse, France Electronic address
    Eur Neuropsychopharmacol 24:95-104. 2014
    ..Meanwhile, use of SGAs continuously increased from 0.37% to 0.64%. Antipsychotic use decreased in the elderly between 2003 and 2011, especially in dementia. The timing of the decrease, however, did not coincide with safety warnings. ..
  2. doi request reprint Diffusion of antipsychotics in the US And French markets, 1998-2008
    Adeline Gallini
    Department of Epidemiology, University of Toulouse, 37 Allees Jules Guesde, Toulouse 31000, France
    Psychiatr Serv 64:680-7. 2013
    ..Little is known about how second-generation antipsychotics have diffused in other countries with different health systems. The study objective was to describe trends in antipsychotic use in the United States and France from 1998 to 2008...
  3. doi request reprint Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease
    Adeline Gallini
    INSERM, UMR1027, 31062, Toulouse, France
    Drugs Aging 30:439-45. 2013
    ..Previous studies have reported a lower use of analgesics in patients with Alzheimer's disease (AD) than in non-AD elderly. To date, no study has focused on persistent analgesic use in patients with mild-to-moderate AD...
  4. doi request reprint A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe : Predictors of Discontinuation and Switch in the ICTUS Study
    Virginie Gardette
    Inserm UMR1027, 31073, Toulouse, France
    CNS Drugs 28:157-70. 2014
    ..There is no consensus on when and how to discontinue cholinesterase inhibitors (ChEI). Predictors of non-persistency of antidementia drugs have been poorly investigated, mostly during short-term periods and using administrative data...
  5. pmc The influence of drug use in university hospitals on the pharmaceutical consumption in their surrounding communities
    Adeline Gallini
    Épidémiologie et Analyses en Santé Publique, INSERM, UMR 1027, Toulouse, France
    Br J Clin Pharmacol 75:1142-8. 2013
    ..To investigate the influence of hospital drug choices on pharmaceutical consumption for nine competitive classes in the surrounding community...
  6. pmc Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes
    Adeline Gallini
    INSERM, UMR 1027 Epidémiologie et analyses en santé publique risques, maladies chroniques et handicaps Université de Toulouse, UPS Toulouse 3, France
    Br J Clin Pharmacol 72:823-31. 2011
    ..To give a panorama of the selectivity and agreement of French university hospitals' drug formularies (HDF) for nine competitive classes...